PLEURISY BACTERIAL

PLEURISY BACTERIAL was reported 41 times

PLEURISY BACTERIAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Echinocandin Antifungal [EPC] 3 0.0004
1 Neonatal Fc Receptor Blocker [EPC] 1 0.0002
2 Antimalarial [EPC] 2 0.0002
3 Antiprotozoal [EPC] 2 0.0002
4 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
5 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1 0.0002
6 Tetracycline-class Antibacterial [EPC] 1 0.0001
7 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
8 Penem Antibacterial [EPC] 3 0.0001
9 Programmed Death Receptor-1 Blocking Antibody [EPC] 7 0.0001
10 Rifamycin Antibacterial [EPC] 2 0.0001
11 Orexin Receptor Antagonist [EPC] 1 0.0001
12 Glycopeptide Antibacterial [EPC] 3 0.0000
13 Macrolide Antimicrobial [EPC] 2 0.0000
14 Aminoglycoside Antibacterial [EPC] 1 0.0000
15 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
16 Azole Antifungal [EPC] 2 0.0000
17 Nucleoside Analog Antiviral [EPC] 1 0.0000
18 Nonsteroidal Anti-inflammatory Drug [EPC] 15 0.0000
19 Prostaglandin Analog [EPC] 1 0.0000
20 Interleukin-4 Receptor alpha Antagonist [EPC] 5 0.0000
21 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
22 Corticosteroid [EPC] 10 0.0000
23 Fluoroquinolone Antibacterial [EPC] 1 0.0000
24 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
25 Microtubule Inhibitor [EPC] 1 0.0000
26 Kinase Inhibitor [EPC] 3 0.0000
27 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
28 Mood Stabilizer [EPC] 1 0.0000
29 Anti-epileptic Agent [EPC] 1 0.0000
30 Platinum-based Drug [EPC] 1 0.0000
31 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
32 beta-Adrenergic Blocker [EPC] 1 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Loop Diuretic [EPC] 1 0.0000